Related Experiment Video
Updated: Mar 8, 2026

The Hypoxic Ischemic Encephalopathy Model of Perinatal Ischemia
Published on: November 19, 2008
[Influence of the antihypoxantic therapy on children with generalized peritonitis]
V A Zavyalkin1, M A Barskaya1, A V Varlamov2
1Samara State Medical University, Ministry of Health of Russia.
Insights
Optimized fluid therapy using reamberin and remaxol improved treatment outcomes for pediatric purulent peritonitis. This approach reduced intoxication and inflammation, with long-term benefits for vascular health.
Area of Science:
- Pediatric Surgery
- Critical Care Medicine
- Pharmacology
Background:
- Widespread purulent peritonitis in children presents significant treatment challenges.
- Optimizing fluid therapy is crucial for improving patient outcomes.
Purpose of the Study:
- To evaluate the efficacy of combined fluid therapy with reamberin and remaxol for pediatric purulent peritonitis.
- To assess the impact of this optimized therapy on clinical recovery and long-term vascular health.
Main Methods:
- A study of 269 children (aged 1-15) with purulent peritonitis.
- Comparison of optimized infusion therapy (reamberin alone vs. reamberin and remaxol) alongside laparoscopic surgery.
- Monitoring of inflammatory markers, liver function, and intima-media thickness.
Main Results:
- The combined therapy group showed faster resolution of intoxication symptoms (leukocytosis, fever).
- Improved recovery of liver protein synthesis and reduced inflammatory syndromes were observed.
- The subgroup receiving reamberin and remaxol demonstrated the most significant improvements.
Conclusions:
- Combined infusion therapy with reamberin and remaxol enhances purulent peritonitis treatment in children.
- Long-term follow-up revealed endothelial dysfunction in children post-peritonitis.
- Clinical recommendations aim to mitigate endothelial dysfunction and prevent future vascular pathology.
Aim:
To improve the results of treatment of a widespread purulent peritonitis in children by optimizing fluid therapy includes the use of combined treatment: reamberin and remaxol.
Material And Methods:
We studied 269 patients aged 1 to 15 years with a widespread purulent peritonitis treated at the children's surgical departments in Samara from 2001 to 2015. The study group included 179 children who used the optimized infusion therapy. In the study group was allocated to 2 groups: 69 children in infusion therapy which used reamberin and 110 patients in which treatment was applied reamberin and remaxol. The surgical treatment used laparoscopic sanation of the abdomen. Comprehensive survey included a study of dynamics of the white blood cell count, leukocyte index Kalf-Caliph, erythrocyte sedimentation rate, temperature, total albumin concentration, transaminase levels. Catamnesis studied 48 patients with the definition of complex intima-media thickness in the projection of basilar, brachial and femoral arteries.
Results:
A study compared indicators of both groups, revealed a more rapid reduction of intoxication symptomps (leukocytosis, LII, body temperature), the disappearance of enteric disease, recovery of protein-synthetic function of the liver, decrease of cytolytic and mesenchymal-inflammatory syndromes in the main group, especially in the subgroup in which treatment was included remaxol.
Conclusion:
The use of reamberin and remaxol in infusion therapy led to improvement of the results of the treatment of common purulent peritonitis in children. Study catamnesis with the study of the intima-media revealed that children undergoing widespread purulent peritonitis further develop signs of endothelial dysfunction. The developed clinical recommendations to significantly reduce the risk of developing signs of endothelial dysfunction, thereby reducing the possible appearance of vascular pathology in patients who underwent childhood widespread purulent peritonitis.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Pharmacokinetics in Pediatric Patients: Drug Distribution
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

